Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: R37AI054165
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: UM1AI068635
Henry M. Jackson Foundation
Grant: W81XWH-18-2-0040
NIH HHS
Grant: S10 OD028685
NIAID NIH HHS
Grant: P30 AI036214
NIAID NIH HHS
Grant: UM1 AI068614
National Institutes of Health
Grant: 1S10OD028685-01
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
National Institutes of Health
Grant: 5R37AI054165-12
Statistical Methods in HIV Vaccine Efficacy Trials
FWCI
5.04
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
HVTN703/HPTN081 + HVTN704/HPTN085 AMP Trials Genotypic Sieve Analysis